Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial

Inclusion Criteria: * Adults aged 30 to 70 years. * Diagnosed with Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA) criteria. * HbA1c levels between 6.5% and 10% at screening. * Stable diabetes management regimen (medications and lifestyle) for at least three months prior to enrollment Exclusion Criteria: * Presence of severe diabetic complications (e.g., end-stage renal disease, proliferative diabetic retinopathy). * History of photosensitivity or medical conditions exacerbated by light exposure. * Use of medications or supplements known to significantly alter glucose metabolism, other than current stable diabetes management. * Pregnant or lactating women.